2BBBullish & Bearish
NovoCure Limited (NVCR) trades on NASDAQ. It operates in the Health Care sector, Medical Instruments & Supplies industry. Its current 2BB score is 48 out of 100.
NovoCure Limited’s current 2BB score is 48 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 52 | Moderate |
| Momentum | 50 | Stable |
| Financial strength | 30 | Weak |
| Quality | 92 | Very Strong |
| Risk | 41 | Moderate (provisional) |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-10-29 | — | -0.2492 | — | $185.88M |